Christopher H. Lieu, MD

home / authors / christopher-h-lieu-md

Articles

Clinical Trials in Progress: CIRCULATE-US

Arvind Dasari, MD, MS;Christopher H. Lieu, MD

October 14th 2022

Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease (CIRCULATE-US): a prospective phase 2/3 trial of MRD-based adjuvant therapy for patients with early-stage colon cancer with intensified and deintensified adjuvant therapy approaches using ctDNA status as a surrogate for MRD status (NRG-GI008) (NCT05174169).

Minimal Residual Disease–Directed Adjuvant Therapy for Patients With Early-Stage Colon Cancer: CIRCULATE-US

Ibrahim Halil Sahin, MD;Yan Lin, PhD;Greg Yothers, PhD;Peter C. Lucas, MD, PhD;Dustin Deming, MD;Thomas J. George, MD;Scott Kopetz, MD, PhD;Christopher H. Lieu, MD;Arvind Dasari, MD, MS

October 14th 2022

Ibrahim Halil Sahin, MD, and colleagues, explore, the CIRCULATE-US (NRG-GI008; NCT05174169) investigating postoperative ctDNA dynamics in early-stage colon cancer for treatment selection.